# Pulmonary Embolism International THrOmbolysis Study-3

Study · id `cardio:ct-nct04430569` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04430569](<https://clinicaltrials.gov/study/NCT04430569>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04430569

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 800 participants.

## Technical summary

Registry record NCT04430569. Randomized; triple masking; primary purpose treatment. Start 2021-08-04 (actual); primary completion 2026-04-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT04430569, source copy `cardio:ctgov-nct04430569-2026-07-01`, retrieved 2026-10-31)
- Started: 2021-08-04 (actual) (ClinicalTrials.gov record NCT04430569, source copy `cardio:ctgov-nct04430569-2026-07-01`, retrieved 2026-10-31)
- Primary completion: 2026-04-13 (actual) (ClinicalTrials.gov record NCT04430569, source copy `cardio:ctgov-nct04430569-2026-07-01`, retrieved 2026-10-31)
- Completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT04430569, source copy `cardio:ctgov-nct04430569-2026-07-01`, retrieved 2026-10-31)
- Countries: Austria; Belgium; Canada; France; Germany; Italy; Netherlands; Poland; Portugal; Romania; Serbia; Slovenia; Spain; Switzerland (ClinicalTrials.gov record NCT04430569, source copy `cardio:ctgov-nct04430569-2026-07-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04430569-2026-07-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pulmonary Embolism International THrOmbolysis Study-3
- Acronym: PEITHO-3
- Condition: Pulmonary Embolism
- Intervention (Drug): Alteplase
- Intervention (Drug): Placebo
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER
- Collaborator: Johannes Gutenberg University Mainz
- Collaborator class: OTHER
- Collaborator: Life Sciences Research Partners (D Collen Research Foundation)
- Collaborator class: UNKNOWN
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV
- Collaborator: Instituto de Salud Carlos III
- Collaborator class: OTHER\_GOV
- Collaborator: International Network of VENous Thromboembolism Clinical Research Networks
- Collaborator class: UNKNOWN
- Collaborator: Boehringer Ingelheim
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Alteplase (Activase) (`cardio:alteplase`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Johannes Gutenberg University Mainz (`cardio:org-johannes-gutenberg-university-mainz`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)
- Registry lists this organization as a collaborator: Instituto de Salud Carlos III (`cardio:org-instituto-de-salud-carlos-iii`)
- Registry lists this organization as a collaborator: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

## Provenance

Content hash: 097634de6c81b6a74d1cade7f7add0b1eca0a22c3dd82dd604b4ec9ef72dad79
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
